Savaria, François <br/><br/>
Polypharmacy, chronic kidney disease, and benign prostatic hyperplasia in patients with chronic obstructive pulmonary disease newly treated with long-acting anticholinergics.  [electronic resource] 

 -  Respiratory medicine  11 2017 
 - 195-202 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1532-3064 
<br/><br/><label>Standard No.: </label>10.1016/j.rmed.2017.10.023  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Inhalation<br/>Aged<br/>Canada--epidemiology<br/>Cholinergic Antagonists--administration & dosage<br/>Cohort Studies<br/>Comorbidity<br/>Delayed-Action Preparations--administration & dosage<br/>Drug-Related Side Effects and Adverse Reactions--diagnosis<br/>Humans<br/>Incidence<br/>Male<br/>Middle Aged<br/>Polypharmacy<br/>Prevalence<br/>Prostatic Hyperplasia--diagnosis<br/>Pulmonary Disease, Chronic Obstructive--drug therapy<br/>Renal Insufficiency, Chronic--diagnosis<br/>Retrospective Studies<br/>Risk Factors<br/>Urinary Retention--chemically induced